<DOC>
	<DOCNO>NCT00782873</DOCNO>
	<brief_summary>The purpose study evaluate safety propofol-based , gastroenterologist-administered sedation severely obese patient ( BMI≥35 ) undergo upper endoscopy . The investigator aim test hypothesis safe use balanced-propofol , gastroenterologist-administered sedation obese patient .</brief_summary>
	<brief_title>Balanced Propofol Sedation During Upper Endoscopy Morbidly Obese Patients</brief_title>
	<detailed_description>The purpose study evaluate safety propofol-based , gastroenterologist-administered sedation severely obese patient ( BMI≥35 ) undergo upper endoscopy . We use change pulmonary hemodynamic parameter primary safety measure study . We compare result 30 non-obese patient 30 obese patient . The term balance propofol sedation refers use low dose propofol combination small amount opioid midazolam .</detailed_description>
	<mesh_term>Propofol</mesh_term>
	<criteria>Undergoing endoscopic esophagostroduodenoscopy ( EGD ) Capable provide write informed consent willing able comply procedure study Adults age 18 85 inclusive ( legal age consent ) ASA score I , II , III Severe acute illness resolve stabilized prior enrollment . Study entry base investigator 's judgment Need sleep narcotic analgesic medication continuous basis proceed 6 month Pregnancy A history drug addiction alcohol abuse within past 12 month . Alcohol consume moderation . The consumption alcohol within routine pattern individual study . A history seizure disorder . Allergy propofol , soy bean , egg . Prior history difficult intubation . Prior history severe complication conscious sedation . Study entry base investigator 's judgment .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>October 2008</verification_date>
	<keyword>propofol</keyword>
	<keyword>sedation</keyword>
	<keyword>safety</keyword>
	<keyword>obesity</keyword>
</DOC>